Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes

Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes

Vaccine technology is still facing challenges regarding some infectious diseases, which can be addressed by innovative drug delivery systems. In particular, nanoparticle-based vaccines combined with new types of adjuvants are actively explored as a platform for improving the efficacy and durability...

Full description

Bibliographic Details
Main Authors: Myriam Lamrayah, Capucine Phelip, Renaud Rovera, Céline Coiffier, Nora Lazhar, Francesca Bartolomei, Evelyne Colomb, Bernard Verrier, Claire Monge, Sophie Richard
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Molecules
Subjects:
poloxamer
vaccine
adjuvant
subcutaneous
lymph node
nanoparticles
Online Access:https://www.mdpi.com/1420-3049/28/12/4778

Internet

https://www.mdpi.com/1420-3049/28/12/4778

Similar Items